このエントリーをはてなブックマークに追加
ID 63817
FullText URL
Author
Sukegawa, Shintaro Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons
Sukegawa, Yuka Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Hasegawa, Kazuaki Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Ono, Sawako Department of Pathology, Kagawa Prefectural Central Hospital
Nakamura, Tomoya Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital
Fujimura, Ai Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital
Fujisawa, Ayaka Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital
Nakano, Keisuke Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Takabatake, Kiyofumi Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID publons researchmap
Kawai, Hotaka Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Mukainaka, Yumika Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Nagatsuka, Hitoshi Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID publons researchmap
Furuki, Yoshihiko Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital
Abstract
We analyzed the rate of patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) infection diagnosed by pre-operative screening and estimated its cost. We retrospectively analyzed patients who underwent elective surgery at our maxillofacial surgery department between April 2014 and March 2022. We compared the number of patients with each infection identified by pre-operative screening and a pre-operative questionnaire. We also compared the prevalence of infections with varying age, sex, and oral diseases, and calculated the cost of screening per positive result. The prevalence of HBV, HCV, and HIV was 0.39% (62/15,842), 0.76% (153/15,839), and 0.07% (10/12,745), respectively. The self-reported rates were as follows: HBV, 63.4% (26/41); HCV, 50.4% (62/123); HIV, 87.5% (7/8). Differences in sex were statistically significant for all infectious diseases; age significantly affected HBV and HCV rates. There was no association between the odds ratio of oral disease and viral infections. The cost per positive result was $1873.8, $905.8, and $11,895.3 for HBV, HCV, and HIV, respectively. Although self-assessment using questionnaires is partially effective, it has inadequate screening accuracy. Formulating an auxiliary diagnosis of infectious diseases with oral diseases was challenging. The cost determined was useful for hepatitis, but not HIV.
Keywords
hepatitis B
hepatitis C
human immunodeficiency virus
pre-operative examination
Published Date
2022-07-20
Publication Title
Healthcare
Volume
volume10
Issue
issue7
Publisher
MDPI
Start Page
1348
ISSN
2227-9032
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2022 by the authors.
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.3390/healthcare10071348
License
https://creativecommons.org/licenses/by/4.0/
Citation
Sukegawa, S.; Sukegawa, Y.; Hasegawa, K.; Ono, S.; Nakamura, T.; Fujimura, A.; Fujisawa, A.; Nakano, K.; Takabatake, K.; Kawai, H.; et al. The Effectiveness of Pre-Operative Screening Tests in Determining Viral Infections in Patients Undergoing Oral and Maxillofacial Surgery. Healthcare 2022, 10, 1348. https://doi.org/10.3390/healthcare10071348
Funder Name
Japan Society for the Promotion of Science
助成番号
JP19K19158
JP20K10178
JP20K10094
JP20H03888
JP21K10043
JP21K17089